Natera
NTRA
$106.46
Share price
-1.88%
Change (1 day)
109.86%
Change (1 year)
Categories
Natera (NTRA) - P/B ratio
P/B ratio as of May 2024 : 17.1
According to Natera's latest financial reports the company has a price-to-book ratio of 17.1.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Natera - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 9.83 | 58.46% |
| 2022-12-31 | 6.21 | -54.11% |
| 2021-12-31 | 13.5 | -22.61% |
| 2020-12-31 | 17.5 | 85.31% |
| 2019-12-31 | 9.43 | -65.01% |
| 2018-12-31 | 26.9 | 41.69% |
| 2017-12-31 | 19.0 | 230.12% |
| 2016-12-31 | 5.76 | 95.76% |
| 2015-12-31 | 2.94 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | 6.53 | -61.74% | 🇺🇸 USA |
 Prothena PRTA | 2.16 | -87.37% | 🇮🇪 Ireland |
 Paratek Pharmaceuticals
PRTK | -0.6348 | -103.72% | 🇺🇸 USA |